Efficacy and Safety of Bromfenac 0.09% and Sodium Hyaluronate 0.4% Combination Therapy, Versus Placebo in Patients With Pterygium I–III for Clinical Signs on Ocular Inflammation
Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s203648
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2019
Authors
Publisher
Informa UK Limited